{
    "code": "51R00038",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51R00038",
    "time": "2021-01-29 05:00:23",
    "許可證字號": "衛部藥製字第R00038號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/03\/24",
    "發證日期": "109\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY051R0003803",
    "中文品名": "氟攝糖造影注射劑",
    "英文品名": "GMS Fludeoxyglucose F-18 Injection",
    "適應症": "肺癌、大腸癌、淋巴瘤、黑色素瘤、冠心病、癲癇之偵測。",
    "劑型": "270注射劑",
    "包裝": "1mL至5mL塑膠注射針筒裝，附屏蔽鎢罐 1mL至25mL玻璃小瓶裝，附屏蔽鎢罐",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新單位含量",
    "監視期限": "",
    "主成分略述": "2-Deoxy-2-[18F]fluoro-D-glucose",
    "限制項目": "01國　產 26監視期滿新藥",
    "申請商名稱": "1432501100  臺灣新吉美碩股份有限公司",
    "申請商地址": "台北市大安區復興南路一段237號11樓",
    "主製造廠": [
        {
            "製造廠名稱": "6103180030  臺灣新吉美碩股份有限公司臺中藥廠",
            "製造廠廠址": "臺中市霧峰區霧工六路16號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7800000200",
            "成分名稱": "2-Deoxy-2-[18F]fluoro-D-glucose",
            "含量描述": "1-10mCi (at calibration time)",
            "含量": "10.0000000000",
            "單位": "MCI"
        }
    ],
    "仿單外盒": [
        {
            "title": "FDG+PI_final_V2-109-11-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51R00038&Seq=002&Type=9"
        },
        {
            "title": "外包裝核定本-109-11-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51R00038&Seq=002&Type=8"
        },
        {
            "title": "FDG label-109-05-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51R00038&Seq=001&Type=8"
        }
    ]
}